# Dexcom: company

Canonical ID: `fd5648f6-a93c-460e-918c-021449c44e97`

## Key facts

- **Product:** Stelo OTC glucose biosensor (first FDA-cleared OTC CGM, De Novo Mar 2024) + gen-AI insights (Vertex/Gemini).
- **Boundary:** Glucose-biometric + real AI -> in-definition INCLUDE (not a bare sensor).
- **wikipedia:** https://en.wikipedia.org/wiki/Dexcom
- **wikidata:** https://www.wikidata.org/wiki/Q15109865

- **Slug:** dexcom
- **Status:** public (NASDAQ: DXCM)
- **Founded:** 1999
- **HQ:** San Diego, California, USA

## Models

- [Stelo](/models/stelo.md) (biometric) (id: `d3f4598c-3c0a-4a99-a235-d0d94eebf947`)

## Supplies to

_No verified supply relationships on file. Supply-chain coverage is being added across the registry; check back as the seed populates this company's outbound edges._

_Outbound supply edges. Each appears when verified with at least two strong sources. Sources are append-only; corrections add new sources rather than rewrite history._

## Sources (3)

1. https://investors.dexcom.com/news/news-details/2024/Stelo-by-Dexcom-First-Glucose-Biosensor-to-be-Cleared-by-FDA-as-Over-the-Counter/default.aspx
2. https://investors.dexcom.com/news/news-details/2024/Dexcom-Launches-the-First-Generative-AI-Platform-in-Glucose-Biosensing/default.aspx
3. https://www.medtechdive.com/news/dexcom-gen-ai-feature-stelo-cgm/735918/

_API: GET /v1/companies/fd5648f6-a93c-460e-918c-021449c44e97 · canonical URL: /companies/dexcom_